101 related articles for article (PubMed ID: 12821613)
1. More than just hype.
Fitchett D
CMAJ; 2003 Jun; 168(13):1646-7; author reply 1647-8. PubMed ID: 12821613
[No Abstract] [Full Text] [Related]
2. More than just hype.
Yusuf S; Dagenais G
CMAJ; 2003 Jun; 168(13):1646; author reply 1647-8. PubMed ID: 12821614
[No Abstract] [Full Text] [Related]
3. More than just hype.
Sigal RJ
CMAJ; 2003 Jun; 168(13):1647; author reply 1647-8. PubMed ID: 12821615
[No Abstract] [Full Text] [Related]
4. The renin angiotensin system and cardiovascular disease: hope or hype?
Williams B
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):142-6. PubMed ID: 11967805
[No Abstract] [Full Text] [Related]
5. [The reduction of cardiovascular risk with ramipril].
Vanuzzo D
Ital Heart J Suppl; 2000 May; 1(5):713-4. PubMed ID: 10834142
[No Abstract] [Full Text] [Related]
6. The HOPE study: comparison with other trials of secondary prevention.
Otterstad JE; Sleight P
Eur Heart J; 2001 Aug; 22(15):1307-10. PubMed ID: 11465962
[No Abstract] [Full Text] [Related]
7. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
[No Abstract] [Full Text] [Related]
8. Ramipril use in Canada: HOPE or HYPE?
Pilote L
CMAJ; 2003 Mar; 168(5):568-9. PubMed ID: 12615751
[No Abstract] [Full Text] [Related]
9. ACE inhibitors to prevent cardiovascular events in high-risk patients.
VandeKieft GK
J Fam Pract; 2000 Apr; 49(4):373-4. PubMed ID: 10778846
[No Abstract] [Full Text] [Related]
10. Effect of ramipril on cardiovascular events in high-risk patients.
O'Rourke MF; Nichols WW
N Engl J Med; 2000 Jul; 343(1):64-5; author reply 66. PubMed ID: 10896544
[No Abstract] [Full Text] [Related]
11. The HOPE study.
Bargout R
Cleve Clin J Med; 2000 Jun; 67(6):452. PubMed ID: 10860230
[No Abstract] [Full Text] [Related]
12. Effect of ramipril on cardiovascular events in high-risk patients.
Weinsaft JW
N Engl J Med; 2000 Jul; 343(1):64; author reply 66. PubMed ID: 10896543
[No Abstract] [Full Text] [Related]
13. ACE in the hole for heart patients...
Health News; 1999 Dec; 5(15):5. PubMed ID: 10633584
[No Abstract] [Full Text] [Related]
14. More hype than HOPE.
Moutsatsos GD
Hypertension; 2003 Apr; 41(4):e4; author reply e5. PubMed ID: 12623866
[No Abstract] [Full Text] [Related]
15. [Experiences with the realisation of innovative study designs using the example of the HOPE-study].
Rangoonwala B
Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S82-5. PubMed ID: 15988674
[No Abstract] [Full Text] [Related]
16. Vitamin E does not prevent cardiovascular events in high-risk patients.
Flynn T; Stevermer JJ
J Fam Pract; 2000 Apr; 49(4):372-3. PubMed ID: 10778845
[No Abstract] [Full Text] [Related]
17. Should you take an ACE inhibitor?
Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):1-2. PubMed ID: 10740441
[No Abstract] [Full Text] [Related]
18. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].
Traut V
Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292
[No Abstract] [Full Text] [Related]
19. Who is fooling us?
Mourad JJ; Safar ME; O'Rourke MF
Lancet; 2002 Jul; 360(9326):89. PubMed ID: 12114069
[No Abstract] [Full Text] [Related]
20. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]